FDA and Officials Launch Crackdown on Kratom-Derived Synthetic Opioids
TL;DR Summary
The FDA and health officials are planning to announce measures to crack down on synthetic products containing 7-OH, a potent opioid-like substance derived from kratom, which is increasingly found in various consumer products and raises safety concerns.
- FDA to announce crackdown on synthetic substance derived from kratom The Washington Post
- Watch live: RFK Jr., health officials outline response to synthetic opioid derived from kratom The Hill
- Secretary Kennedy, Deputy Secretary O’Neill, Commissioner Makary, and U.S. Senator Mullin to Host Press Conference on Measures to Safeguard American Public from Dangerous Opioid 7-OH HHS.gov
- FDA Issues Warning Letters for Products Containing 7-Hydroxymitragynine The National Law Review
- LIVE NOW: HHS, FDA, and Sen. Mullin to Announce Action on Opioid 7-OH NTD News
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
61%
94 → 37 words
Want the full story? Read the original article
Read on The Washington Post